跳至主要内容
临床试验/ACTRN12611001174976
ACTRN12611001174976已完成未知

A randomised control trial evaluating the functional, neurological and participation outcomes of the Move it To improve it program for children with congenital Hemiplegia

Smart Futures Coinvestment Fund0 个研究点目标入组 102 人开始时间: 2011年11月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
102

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
8 Years 至 18 Years(—)
性别
All

入选标准

  • i. Gross Motor Function Classification (GMFCS) I or II; Manual Abilities (MACs) I, II, III. ii. Sufficient co-operation and cognitive understanding to perform the tasks and access the computer equipment; iii. Are able to attend 3 appointments in Brisbane for initial assessment/training and follow-up assessments. iv. Able to access the internet at home (phone line or internet access). Note; laptops will be loaned for those require them and camera’s provided for all children with the treatment phase.

排除标准

  • i. received upper limb surgery in the last 6mths; ii. unstable epilepsy (i.e. not controlled by medication) is a precaution for TMS. Where children have received BoNT-A or upper limb casting in the previous 1 month, inclusion in the study will be delayed until after treatment and standard follow up.

研究者

发起方
Smart Futures Coinvestment Fund

相似试验